ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 1.7.2 (20 November 2019) - 2999001/02906684CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120200902W173deBibliographieenBibliographyfrBibliographieEP13845951.6201310102015050520180523enenen201261712028 P20121010US2020090220203620150819201534202007222020302020012820200902202036C12N 5/0783 20100101AFI20200102BHEP C12N 15/00 20060101ALI20200102BHEP C12N 15/87 20060101ALI20200102BHEP A61K 35/17 20150101ALI20200102BHEP C07K 16/28 20060101ALN20200102BHEP deT-ZELL-MODIFIZIERENDE VERBINDUNGEN UND VERWENDUNGEN DAVONenT CELL MODIFYING COMPOUNDS AND USES THEREOFfrCOMPOSÉS MODIFIANT LES LYMPHOCYTES T ET LEURS UTILISATIONSWO-A2-2008/153742US-A1- 2011 158 957US-A1- 2011 158 957BERGER C ET AL: "Adoptive transfer of virus-specific and tumor-specific T cell immunity", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), pages 224-232, XP026058400, ISSN: 0952-7915, DOI: 10.1016/J.COI.2009.02.010 [retrieved on 2009-03-21]H. TORIKAI ET AL: "A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR", BLOOD, vol. 119, no. 24, 14 June 2012 (2012-06-14), pages 5697-5705, XP055071623, ISSN: 0006-4971, DOI: 10.1182/blood-2012-01-405365PADMANEE SHARMA ET AL: "Novel cancer immunotherapy agents with survival benefit: recent successes and next steps", NATURE REVIEWS CANCER, vol. 11, no. 11, 24 October 2011 (2011-10-24), pages 805-812, XP055110127, ISSN: 1474-175X, DOI: 10.1038/nrc3153KALOS MICHAEL ET AL: "T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia", 20110810, vol. 3, no. 95, 10 August 2011 (2011-08-10), page 95ra73.1, XP002667262,DREW M. PARDOLL: "The blockade of immune checkpoints in cancer immunotherapy", NATURE REVIEWS CANCER, vol. 12, no. 4, 22 March 2012 (2012-03-22) , pages 252-264, XP055150744, ISSN: 1474-175X, DOI: 10.1038/nrc3239BERGER ET AL.: 'Adoptive transfer of virus-specific and tumor-specific T cell immunity' CURR OPIN IMMUNOL. vol. 21, no. 2, April 2009, pages 224 - 232, XP026058400TORIKAI ET AL.: 'A foundation for universal T- cell based immunotherapy: T cells engineered to express a CD 19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR' BLOOD vol. 119, no. 24, 14 June 2012, pages 5697 - 5705, XP0550716232016032920183942.020200703GREGORY, Philip D.c/o Sangamo BioSciences Inc. Point Richmond Tech Center 501 Canal Blvd. Suite A100Richmond California 94804USHOLMES, Michael C.c/o Sangamo BioSciences Inc. Point Richmond Tech Center 501 Canal Blvd. Suite A100Richmond California 94804USSangamo Therapeutics, Inc.101861117P066037EP7000 Marina BlvdBrisbane, CA 94005USCarpmaels & Ransford LLP101299776One Southampton RowLondon WC1B 5HAGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201306438420131010enWO201405917320140417201416